Sexually Transmitted Infections

Investigators recently noted that despite a decrease in adolescent hospital visits during the height of the pandemic, there was an increase in sexually transmitted infections (STIs) in this population group.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study explores how changing sexual behaviors influence rising sexually transmitted infection rates, underscoring the need for comprehensive prevention strategies.

The FDA emphasized the need for cautious herpes simplex virus type 2 serological testing, highlighting factors that increase the likelihood of false positives and urging adherence to CDC guidelines.

A 755% increase in reported cases since 2012 highlights the need for timely testing and treatment to prevent maternal and infant health risks.

In a recent study, high rates of reinfection were seen among patients who tested positive for Trichomonas vaginalis.

In a recent study, certain sexually transmitted infections were more common among patients positive for bacterial vaginosis.

The new lab will help prevent the spread of sexually transmitted infections in the United States.

Jonathan Miller, MD, pediatrician and chief of primary care, pediatrics at Nemours Children’s Health in the Delaware Valley, spoke about the latest data regarding early human papillomavirus (HPV) vaccination in children as young as 9 years old at the 2023 Pediatric Academic Societies meeting. He also provided some clinical pearls for opening the conversation with patients’ caretakers regarding earlier HPV vaccination.

In a recent study, doxycycline use reduced the incidence of sexually transmitted infections among transgender women and men who have sex with men.

The cumulative probabilities of treatment initiation after meeting the criteria was not significantly different between the different racial groups and the incidence of major adverse liver outcomes was 0.1 per 100 person-years and did not differ by race.

Investigators performed an economic evaluation of the HOME trial, which found increased rates of screening when human papillomavirus (HPV) self-sampling kits were mailed to participants, and found this process was cost-effective compared to usual care.

The patient, referred to as the “New York patient,” was treated with stem cells from cord blood, and has remained HIV-free in her blood since her transplant in 2017.

In a recent review, children with vaccination against human papillomavirus (HPV) initiated at a younger age were more likely to receive their full vaccination series.

Visby Medical has announced its second generation point of care test for detecting sexually transmitted diseases in women has received 510(k) clearance and a CLIA waiver from the FDA.

The new guidance is the first update since 2008, replacing the previous risk-based recommendations.

The therapy, bepirovirsen, is an antisense oligonucleotide that targets all Hepatitis B (HBV) messenger RNAs, and the company is hoping it will become a functional cure.

Individuals that did not respond had a lower percentage of naïve T cells compared to responders, while responders had a lower percentage of Th2 and CD4 central memory subsets before vaccination.

A recent study highlights barriers to pregnancy prevention for women without permanent housing.

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases (STDs) to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

The handheld STI testing device makes its way into pediatric urgent care clinics across Alabama, Tennessee, and Louisiana.

Consensus group discussion resulted in a shift from results-based to risk-based management for cervical cancer screening.

A study found trans people were not substantively included in many countries’ HIV national strategic plans, despite being disproportionately impacted by HIV/AIDS.

People are being diagnosed with chlamydia and gonorrhea at a higher rate than ever before, according to the Centers for Disease Control and Prevention (CDC).

New guidelines from the Centers for Disease Control and Prevention (CDC) for the screening of sexually transmitted infections (STIs) offer new ways to ask common questions.

A cross-sectional study in the journal Sexually Transmitted Infections has found that Mycoplasma genitalium (MG) is just as prevalent as Chlamydia trachomatis (CT) among women seen at a sexual health center in Australia.

The CDC updated its guidelines for diagnosing and treating STIs, which included updates on the diagnosis and treatment of bacterial vaginosis (BV) in pregnant and nonpregnant women.

For cervical cancer screening, human papillomavirus (HPV)–based screening modalities detect significantly more abnormal cervical cells than traditional liquid-based cytology (LBC) approaches, according to a study in JAMA Network Open.

Significant updates occurred in women’s health issues while the world was in survival mode.

A narrative review identified gaps in knowledge and considerations for informing sexually transmitted infection (STI) screening guidelines and treatment to improve the health of pregnant women and children.